Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid (Keloid)
Keloid
About this trial
This is an interventional treatment trial for Keloid focused on measuring Keloid, Allogeneic Mesenchymal Stem Cells, Umbilical Cord, Conditioned Medium
Eligibility Criteria
Inclusion Criteria:
- Surgery history of more than 3 months
- Has keloid that the maximum size is 15 cm and thickness is 3-5 mm
Exclusion Criteria:
- Patients with kidney failure
- Pregnancy
- Breastfeeding
- Liver dysfunction
- Blood disorders
- Currently receiving immunosuppressant therapy (chemotherapy or steroids)
- Refusing to participate in the study
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
UC-MSCs + CM
CM + CM
Triamcinolon acetonide
A patient will be given UC-MSCs 2 million cells / cm3. After 3 weeks, the patient will be given CM 1 cc / cm3. The maximum size of Keloid is 15 cm per patient.
A patient will be given CM 1 cc / cm3. After 3 weeks, the patient will be given CM 1 cc / cm3. The maximum size of Keloid is 15 cm per patient.
A patient will be given Triamcinolone acetonide 40 mg / cc / cm3. After 3 weeks the patient will be given Triamcinolone acetonide 40 mg/cc / cm3. The maximum size of Keloid is 15 cm per patient.